Skip to main content
. 2018 Sep 12;7(9):274. doi: 10.3390/jcm7090274

Figure 1.

Figure 1

Odds ratio of Norepinephrine user on the development of 90 days mortality. Odds ratio of Norepinephrine users (vs. other vasoactive agents) on the development of 90-day mortality, according to demographics in septic shock patients at dialysis initiation. Patients those who had respiratory tract infection, congestive heart failure, diabetes mellitus, BUN with more than 64 mg/dL, and did not have cerebrovascular disease tended to have a higher 90-day mortality while norepinephrine (NE) was prescribed.